Targeted treatment matches genetic profile to fight salivary gland cancer

NCT ID NCT06145308

First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 24 times

Summary

This study tests whether giving targeted drugs or chemotherapy based on specific genetic markers (like HER2, NTRK, AR, TROP-2) can shrink or control salivary gland cancer. About 39 adults with advanced or recurrent cancer will receive personalized treatment. The goal is to see how well these precision therapies work and how safe they are.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SALIVARY GLAND CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fei Ma

    RECRUITING

    Beijing, Beijing Municipality, 100021, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

    RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.